Has Ki Buom Lee, MD received payments from drug or device companies?

Yes. Drug and device makers reported $9,347 in general payments to Ki Buom Lee, MD across 142 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ki Buom Lee, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ki Buom Lee, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ki Buom Lee, MD

Internal Medicine · Las Vegas, NVNPI 1730683996

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $5,685 of the $9,347 with a category attached, or 60.8%. 19 manufacturers reported payments, led by Abbott at 45.8% of the total. 2025 is the largest year on record at $4,613, 2.3 times the $2,049 reported in 2023. Among internal medicine clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,347in general payments, 2019–2025

Across 142 payments — averaging $65.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Abbott$4K
Abiomed$1K
Medtronic$670
Boston Scientific$629
Lantheus Medical Imaging, Inc.$538
E.r. Squibb & Sons, L.L.C.$346
plus $2K from 13 others

What the payments were for

Grants$5256%
Travel & lodging$1,79019%
Food & beverage$5,68561%
Education$1,34714%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Abbott	29	$4,280
Abiomed	41	$1,036
Medtronic	5	$670
Boston Scientific	3	$629
Lantheus Medical Imaging, Inc.	17	$538
E.r. Squibb & Sons, L.L.C.	9	$346
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)	7	$310
Edwards Lifesciences	2	$281
Biosense Webster, Inc.	6	$251
Novo Nordisk	4	$191
Astellas Pharma US Inc	2	$176
Novartis	7	$155
Lexicon Pharmaceuticals, Inc.	2	$146
Scpharmaceuticals Inc.	1	$120
Chiesi USA, Inc.	1	$84
Pfizer	2	$42
Philips North America LLC	2	$41
Actelion Pharmaceuticals US, Inc.	1	$27
Boehringer Ingelheim	1	$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

OPTIS$2,082
ENSITE$539
AVEIR$438
RESOLUTE ONYX$404
GALLANT$285
Definity$267
Impella$244
FFRangio$174
PASCAL$149
COROFLOW$145
CARDIOMEMS$142
Edwards SAPIEN 3 Transcatheter Heart Valve$132
Inpefa$122
FUROSCIX$120
Carto 3$115
WATCHMAN Access System$104
CAMZYOS$104

How this compares

$9,347 in reported general payments places this provider in the 90th percentile of 1,071 internal medicine providers in Nevada.

See all internal medicine providers in Nevada →

Medicare billing

Part B allowed, 2024

$8,370

Medicare patients

Services billed

132

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ipratropium Bromide	37	$690
Diclofenac Sodium	12	$285
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst	19	$225
Fluticasone Propionate	16	$137
Mupirocin	17	$110
Famotidine	11	$91
Cephalexin	12	$64
Chlorhexidine Gluconate	15	$58
Azithromycin	14	$48
Ibuprofen	17	$48
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	11	$45
Amoxicillin	15	$33

Paid to pharmacies, not to this prescriber.

Other internal medicine in Las Vegas

Kevin DunsmoorLas Vegas$241K
Robert ChiascioneLas Vegas$174K
Dino GonzalezLas Vegas$126K
Rosanne SugayLas Vegas$63K
Chad HallLas Vegas$42K
Zubin DamaniaLas Vegas$40K
Audrey Sue CruzLas Vegas$34K
Bashab BanerjiLas Vegas$26K
Amaan ShafiLas Vegas$25K
Sassan KavehLas Vegas$23K

See the full list for Nevada →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →